Better Quality of Active Life
Enriching every lives through the continuous evolution of medical solutions


Mission
Vision

Top Message


ESG / Sustainability
OSferionBiomaterials Selected for FY2027 Medical Device Industry Enhancement Grant (R&D and Commercialization Program)
OSferionBiomaterials Selected as a Recipient of the FY2027 Intensive Support Program for Next-Generation Medical Device Development and Commercialization
OSferionBiomaterials Corp. and Japan Tissue Engineering Co., Ltd. form business alliance to develop knee joint preservation treatment combining regenerative medicine and osteotomy.